Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/07/2026
The New York Comex gold lost support at $4,050 per ounce, dropping 0.49% intraday.
Latest
2 m ago
The concept of innovative drugs is gaining momentum, with Zhongsheng Pharmaceutical Industry hitting the limit up, and more than ten stocks including Dize Pharmaceutical, Borui Pharmaceutical, Yaokang Biology, Ruizhi Pharmaceutical, Hainan Haiyao, Hasunlian, Haisike, and Zhaoyan New Drugs also hitting the limit up. Shutaishen, Warner Pharmaceutical Factory, Stone Pharmaceutical Innovation, and Changshan Pharmaceutical Industry have also risen by more than 10%.
3 m ago
National Bureau of Statistics on fluctuations in GDP growth rate in the second quarter: mainly influenced by some short-term factors and external factors.
3 m ago
National Bureau of Statistics: Enterprises are paying more attention to research and development innovation and continue to increase investment in areas such as patents and databases.
4 m ago
Sensor Tower: "Whiteout Survival" jumped to the top of the global mobile game revenue chart in June 2026.
4 m ago
Barclays: Goldman Sachs' target price has been raised from $1048 to $1245.
See all latest